Literature DB >> 8301234

Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.

H Chen1, E Born, S N Mathur, F J Field.   

Abstract

There is a presumed association between cellular cholesterol and sphingomyelin metabolism. To study this relationship in the intestine, the activity of the rate controlling enzyme of sphingolipid synthesis, serine palmitoyltransferase (SPT), and the biosynthesis of long-chain bases were characterized in cultured human intestinal cells, CaCo-2. Cells were then incubated with substances known to alter cholesterol biosynthesis, and the effect of these mediators on SPT activity and long-chain base synthesis was determined and compared with their effects on HMG-CoA reductase activity and cholesterol synthesis. The polar sterol, 25-hydroxycholesterol, the squalene epoxide inhibitor, U18666A, and the inhibitor of HMG-CoA reductase, lovastatin, all significantly inhibited the synthesis of cholesterol without altering either SPT activity or long-chain base synthesis. Mevalonate, which increased cholesterol production 3-fold, also had no affect on SPT activity or sphingoid base synthesis. Serine, which significantly increased the synthesis of long-chain bases, did not alter cholesterol biosynthesis. Moreover, the suicide inhibitors of SPT, beta-chloroalanine and cycloserine, did not alter cholesterol synthesis while markedly decreasing long chain base synthesis. Cells were incubated with palmitic, oleic, linoleic, and eicosapentaenoic acids. Only palmitic acid, the preferred substrate for SPT, increased the production of long-chain bases. Both palmitic and oleic acids, however, increased the synthesis of cholesterol. Cells enriched in sphingomyelin had higher rates of synthesis of both cholesterol and long-chain bases compared to their controls. In contrast, cholesterol and long-chain base syntheses were significantly decreased in cells enriched in cholesterol. Control cells incubated with phospholipid liposomes alone had higher rates of synthesis of both lipids.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301234

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Origins of intestinal ABCA1-mediated HDL-cholesterol.

Authors:  F Jeffrey Field; Kim Watt; Satya N Mathur
Journal:  J Lipid Res       Date:  2008-08-18       Impact factor: 5.922

2.  Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.

Authors:  Dan Feng; Lena Ohlsson; Wenhua Ling; Ake Nilsson; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

3.  Betamethasone modulation of sphingomyelin hydrolysis up-regulates CTP:cholinephosphate cytidylyltransferase activity in adult rat lung.

Authors:  R K Mallampalli; S N Mathur; L J Warnock; R G Salome; G W Hunninghake; F J Field
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  ORMDL orosomucoid-like proteins are degraded by free-cholesterol-loading-induced autophagy.

Authors:  Shuhui Wang; Peggy Robinet; Jonathan D Smith; Kailash Gulshan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

5.  Cholesterol regulates oxysterol binding protein (OSBP) phosphorylation and Golgi localization in Chinese hamster ovary cells: correlation with stimulation of sphingomyelin synthesis by 25-hydroxycholesterol.

Authors:  M K Storey; D M Byers; H W Cook; N D Ridgway
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

6.  Cellular Tight Junctions Prevent Effective Campylobacter jejuni Invasion and Inflammatory Barrier Disruption Promoting Bacterial Invasion from Lateral Membrane in Polarized Intestinal Epithelial Cells.

Authors:  Sho Hatayama; Takaaki Shimohata; Sachie Amano; Junko Kido; Anh Q Nguyen; Yuri Sato; Yuna Kanda; Aya Tentaku; Shiho Fukushima; Mutsumi Nakahashi; Takashi Uebanso; Kazuaki Mawatari; Akira Takahashi
Journal:  Front Cell Infect Microbiol       Date:  2018-01-30       Impact factor: 5.293

7.  Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cells.

Authors:  Qi Zhou; Allan Luo; Fred A Kummerow
Journal:  Biochem Biophys Rep       Date:  2015-12-03

8.  Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation.

Authors:  Ádám Horváth; Maja Payrits; Anita Steib; Boglárka Kántás; Tünde Biró-Süt; János Erostyák; Géza Makkai; Éva Sághy; Zsuzsanna Helyes; Éva Szőke
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

9.  Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.

Authors:  Ying Chen; Shu-Chang Xu; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2015-10-22       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.